Leukapheresis Market Players:
- BioLineRx Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Gilead Sciences, Inc.
- Haemonetics Corporation
- Charles River Laboratories
- Fresenius SE & Co.
- StemExpress, LLC
- AllCells, LLC
- Cerus Corporation
- Hemacare Corporation
- Macopharma SA.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of leukapheresis is evaluated at USD 3.49 billion.
The global leukapheresis market size exceeded USD 3.22 billion in 2025 and is set to register a CAGR of around 9.2%, exceeding USD 7.76 billion revenue by 2035.
The North America leukapheresis market achieves a 36% share by 2035, driven by rising neurological and blood disorders and demand for cell therapies.
Key players in the market include BioLineRx Ltd., Gilead Sciences, Inc., Haemonetics Corporation, Charles River Laboratories, Fresenius SE & Co., StemExpress, LLC, AllCells, LLC, Cerus Corporation, Hemacare Corporation, Macopharma SA.
